Publications (1)3.8 Total impact

  • S Kim · J R Jensen · K Cisek · K E Funk · S Naphade · K Schafer · J Kuret
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease is diagnosed by postmortem detection of pathological lesions that accumulate in specific brain regions. Although the presence of both beta-amyloid plaques and tau-bearing neurofibrillary lesions defines Alzheimer's disease, the distribution of neurofibrillary lesions alone correlates strongly with neurodegeneration and cognitive decline. A whole-brain imaging test capable of detecting these lesions in premortem cases could have great potential for staging and differentially diagnosing Alzheimer's disease. Here we discuss the challenges in developing a whole-brain imaging approach for detection of this intracellular target.
    Current Alzheimer research 05/2010; 7(3):230-4. DOI:10.2174/156720510791050894 · 3.80 Impact Factor